Developmental Activities
Developmental Activities
批准号:
7983887
负责人:
CHAD A. MIRKIN
金额:
$13.55万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2015-07-31
关键词:
AcademiaAdministratorAdvisory CommitteesArchitectureAreaArtsBasic ScienceBehaviorBioinformaticsBiologicalBiomedical EngineeringBiophotonicsBudgetsCCNE1 geneCaliforniaCellsChicagoClinicClinicalClinical SciencesCollaborationsCommunitiesComprehensive Cancer CenterCultural DiversityDataDetectionDevelopmentDisciplineDiseaseEngineeringEnsureFacultyFeedbackFoundationsFundingFunding OpportunitiesGelGenderGene Expression RegulationGoalsGrantHeadHospitalsImageIndividualInstitutesInstructionInternationalInterventional radiologyLeadMailsMalignant neoplasm of lungMalignant neoplasm of pancreasManualsMedicalMedical OncologyMedical StaffMedical StudentsMedicineMentorsMethodologyMinorityNanotechnologyNatureOperative Surgical ProceduresOralOutcomeParticipantPhysiciansPilot ProjectsPostdoctoral FellowProcessProgress ReportsPublicationsRecommendationRequest for ProposalsResearchResearch DesignResearch Ethics CommitteesResearch PersonnelResourcesSchoolsScienceScientistScreening for cancerSite VisitSpecific qualifier valueSpectrum AnalysisStagingSubcellular structureTechniquesTechnologyTimeUniversitiesUniversity of Chicago Cancer Research CenterUpdateVisionWomanWorkWritingabstractinganimal carecarcinogenesiscareer developmentdata sharingexpedited reviewflexibilitygraduate studentimprovedin vivoinnovationmedical schoolsmeetingsmembernanoparticlenanoscaleoperationphotonicsprofessorprogramsresearch studysynergism
中文摘要
拟议的NU-CCNE的发展活动将包括三个组成部分:试点项目,
联盟挑战项目和跨联盟活动。自2005年成立以来,目前的NU-CCNE每年都为试点项目提供资金,该计划已被证明在鼓励新的和创新的想法方面至关重要,这些想法将推动当前研究的范围,并有可能显着增强和推进研究目标。以前资助的试点项目为重要的新努力奠定了基础,并/或已被纳入现有的CCNE研究组合。新的NU-CCNE将资助中心内试点项目,并建议将这一机制扩大到联盟间项目。这些提案将通过协同项目涉及联盟网络中的其他中心和平台,这些项目有能力通过共享NU-CCNE的独特资源和优势,快速开发和推进临床技术。最后,我们将继续为跨联盟活动做出贡献,以建立联盟社区,并通过建立生物信息学核心来确保信息和数据共享,通过参与和协助公报和CCNE操作手册来鼓励协同作用。
英文摘要
Developmental activities at the proposed NU-CCNE will include three components: Pilot Projects,
Alliance Challenge Projects, and trans-Alliance activities. The current NU-CCNE has provided funding for pilot projects each year since its inception in 2005, and this program has been shown to be of critical importance in encouraging new and innovative ideas that will push the envelope ofthe current research and have potential to significantly enhance and advance research goals. Previously funded pilot projects have laid the groundwork for important new efforts and/or have been incorporated into the existing CCNE research portfolio. The new NU-CCNE will fund in-Center Pilot Projects, and proposes to expand this mechanism to inter-Alliance projects. These proposals will involve other Centers and Platforms across the Alliance network through synergistic projects that have the capacity to rapidly develop and advance technologies to the clinic by sharing the unique resources and strengths of the NU-CCNE. Finally, we will continue to contribute to trans-Alliance activities in order to build the Alliance community and encourage synergism by establishing a Bioinformatics Core to ensure information and data sharing, by participating in and assisting with the bulletins, and CCNE operation manuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
-
批准号:10539146
-
项目类别:
-
资助金额:$44.35万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
-
批准号:10709540
-
项目类别:
-
资助金额:$42.56万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
-
批准号:10402178
-
项目类别:
-
资助金额:$52.19万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
-
批准号:10591545
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Systemic RNA interference to reactivate p53 tumor suppression
-
批准号:10091404
-
项目类别:
-
资助金额:$35.29万
-
财政年份:2017
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
-
批准号:8962037
-
项目类别:
-
资助金额:$233.23万
-
财政年份:2015
-
负责人:CHAD A. MIRKIN
-
依托单位:
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia
-
批准号:8433345
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing
-
批准号:8513708
-
项目类别:
-
资助金额:$5.85万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia
-
批准号:8237282
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia
-
批准号:8632993
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing
-
批准号:8435386
-
项目类别:
-
资助金额:$19.04万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing
-
批准号:8285048
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Administrative Core
-
批准号:8545729
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8313166
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Administrative Core
-
批准号:7983877
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:7975900
-
项目类别:
-
资助金额:$240.0万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8708292
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8545722
-
项目类别:
-
资助金额:$213.07万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8396702
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8145721
-
项目类别:
-
资助金额:$232.96万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
海外基金